Tralokinumab
The indications for tralokinumab.
What is adult patients with moderate to severe AD who disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable.
The response TSS's will receive when calling the HUB to follow up on a case.
What is h%&#* no, WTF*, or I'm not going to jail because of you?
h%&#= heck
WTF= well, that's fantastic!
Three ways that patients maybe enrolled in Copay program.
What is via the HUB (Nurse Advocate), SP, or On-line?
This is what distinguishes the Nurse Advocate.
What is Territorially aligned and patient facing?
Patient requirement for PharmaCord Support Services.
What is a completed enrollment form? (Patient signature is also acceptable)
Tralokinumab can be used with or without these.
What is topical corticosteroids?
A situation when it is appropriate to communicate with customers (accounts) via email or text.
What is FRM's should never communicate via email or text message?
The 4 critical actions for filing an appeal
What is:
Review payers denial letter, ensure accurate and complete information was submitted in original PA, consider using approved template, including supporting documentation?
Nurse Advocates performs the following 4 outbound services to new patients on therapy.
What is :
Welcome Call
Medication Management
Counseling follow up
First month therapy call?
Resources available to support pre-call planning & payer research.
What is MMIT, Payer Websites, and Pharmacord® HUB Summary of Benefits?
Recommended initial dose for Tralokinumab.
What is an initial dose of 600 mg (4 injections)?
The FRM response when receiving direction or suggested activities from TSS.
What is h%&#* no!, WTF*, or similar comment?
h%&#= heck
WTF= well, that's fantastic!
These three options are considered acceptable patient consent.
What is:
a hard copy signature on enrollment form,
standalone consent form downloaded from website and signed via DocuSign or
verbal consent?
The Nurse Advocate will provide information/education on the following 5 areas.
What is:
-course of treatment for the biologic drug
-insurance coverage benefits & anticipated OOP
-potential resources for FA
-support to manage the stress associated with DX?
Pharmacord® 5 requirements for a completed enrollment form.
What is:
patient contact information, Pharmacy Insurance Information, two sigs. (Patient, Prescriber), & relevant ICD 10 code?
The maintenance dose for tralokinumab?
What is 300 mg (2 injections) every other week?
Potential intervals for Reauthorizations.
What is 3 months, 6 months, 12 months, or longer than 12 months ?
Name three of the common PA clinical documentation requirements by payers.
What is:
DX, DX findings, Lifestyle Modifications, Adtralza experience, TX history, Intolerance or Contraindications to other AD TX, Specialty of HCP?
The Nurse Advocate coordinates this very important step.
What is:
Scheduling of shipment of Rapid Access/Bridge product and PAP product as applicable?
5 of the 8 ways that Pharmacord® provides access and reimbursement support.
What is BV, PA Support, Appeals Support, PA/Appeals Kit, Rapid Access, Bridge program, Copay program, PAP?
U & MAB defined.
What is human Monoclonal AntiBody?
The Payer requirement when patients have an insurance change.
What is a new Prior Authorization?
This is required prior to viewing Protected Health Information (PHI).
What is a signed Patient Enrollment and Prescription from the practice or PharmaCord?
The Nurse Advocate will be able to do the following via the MediSafe App.
What is provide virtual training to patients/care partners, answer non-clinical question, and provide ongoing support?
The three terms of the Adtralza Bridge Program.
What is: Maintenance doses provided to commercially insured patients who are experiencing delay.
Continued participation mandates that HCP complete PA & appeal submission
Eligible patients may receive a max of up to two years?